Skip to main content

Table 3 Analysis of the highly differentially expressed genes following 3MCA injection

From: The transcriptome landscape of the carcinogenic treatment response in the blind mole rat: insights into cancer resistance mechanisms

 

Immune

ECM

Hypoxia

Cell cycle

Citrate cycle

Degenerative diseases

# of genes

HDEGa

125

269

164

239

74

159

888

DEb

43

57

88

84

9

21

220

TSUc S > Md

13

14

8

6

1

5

39

TSU M > Sd

4

4

3

5

–

5

21

TPDe S < Mf

4

7

14

9

–

4

36

TPD M < Sf

4

9

6

6

–

5

27

  1. aHDEG highly differentially expressed genes |log2f| ≥2
  2. bDE Differentially Expressed—the number of HDEG refers to when the difference in the change between the species following the 3-MCA injection is |log2f| ≥1
  3. cTSU Tumor Suppressors Up-regulated
  4. dS > M, M > S: higher elevation in the Spalax compared to the mice, or the mice compared to the Spalax, respectively
  5. eTPD Tumor Promoters Down-regulated
  6. fS < M, M < S: stronger down-regulation in the Spalax compared to the mice, or the mice compared to Spalax, respectively